MedtronicXSWX:MDT +1.21%21 5-Year ROIIC % is 224.15 as of Apr. 2026. GuruFocus rates XSWX:MDT with a GF Score™ of 21/100 and a GF Value™ of CHF80.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 733 Medical Devices & Instruments companies, Medtronic ranks better than 94.41% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Medtronic's 5-Year ROIIC % for the quarter that ended in Apr. 2026 was 224.15%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Medtronic's 5-Year ROIIC % or its related term are showing as below:
XSWX:MDT's 5-Year ROIIC % is ranked better than 94.41% of 733
companies
in the Medical Devices & Instruments industry
Industry Median: 0.82
vs XSWX:MDT: 224.15
Medtronic (XSWX:MDT) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Medtronic 5-Year ROIIC % Related Terms
Medtronic 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Medtronic's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:MDT vs SYK, BSX, EW: 5-Year ROIIC % Comparison
For the Medical Devices subindustry, Medtronic's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medtronic 5-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Medtronic's 5-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Medtronic (XSWX:MDT) has a 5-Year ROIIC % of 224.15 as of Apr. 2026. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Medtronic and its competitors. According to the industry distribution chart, Medtronic ranks #41 out of 733 companies in the Medical Devices & Instruments industry, placing it in the top 5.6%.
Is Medtronic's 5-Year ROIIC % too high?
Medtronic's current 5-Year ROIIC % is 224.15. The Medical Devices & Instruments industry median 5-Year ROIIC % is 0.82. Medtronic's value of 224.15 is 27235.4% above this industry median. Based on the distribution chart, Medtronic ranks #41 out of 733 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medtronic has a GF Score™ of 21/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's 5-Year ROIIC % compare to SYK and BSX?
According to the Medical Devices & Instruments industry distribution chart, Medtronic ranks #41 out of 733 companies for 5-Year ROIIC %. This places Medtronic in the top 6% of its industry — outperforming the majority of peers. The industry median 5-Year ROIIC % is 0.82. Medtronic's value of 224.15 is 27235.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Medical Devices & Instruments company?
The median 5-Year ROIIC % among Medical Devices & Instruments companies is 0.82, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medtronic's current 5-Year ROIIC % of 224.15 is 27235.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Medtronic and its competitors. For the Medical Devices & Instruments industry, the median 5-Year ROIIC % is 0.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medtronic's current 5-Year ROIIC % is 224.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (XSWX:MDT) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF80.97, compared to a current price of CHF65.29 — trading 19.4% below its estimated fair value. The current 5-Year ROIIC % is 224.15 and 27235.4% above the Medical Devices & Instruments industry median of 0.82. Medtronic's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Medtronic (XSWX:MDT), the current 5-Year ROIIC % is 224.15 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medtronic (XSWX:MDT) Overvalued in 2026?
Based on GuruFocus' analysis, Medtronic stock appears to be undervalued.
The current stock price of CHF65.29 is trading 19.4% below its estimated GF Value™ of CHF80.97.
GuruFocus considers Medtronic to be Modestly Undervalued.
Key valuation signals for XSWX:MDT:
5-Year ROIIC %: 224.15
GF Value™: CHF80.97 vs. price of CHF65.29 (19.4% below fair value)
Industry Position: 27235.4% above the Medical Devices & Instruments median (#41 of 733)
No single metric tells the full story. See the XSWX:MDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
21GF Score
Get the complete analysis for XSWX:MDT
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MDT has been successfully added to your 
